NCT00688454View on ClinicalTrials.gov

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

CompletedOBSERVATIONAL
Enrollment

3,392

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

January 31, 2008

Conditions
Hypercholesteremia
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY